Health
Sortilin may hold the key to developing more effective treatment for pancreatic cancer – News-Medical.Net
Pancreatic cancer has an extremely poor prognosis; it is the third most common cause of cancer deaths in the United States.
Reviewed by Emily Henderson, B.Sc.Aug 20 2020
Pancreatic cancer has an extremely poor prognosis; it is the third most common cause of cancer deaths in the United States. In a novel study published in TheAmerican Journal of Pathology, published by Elsevier, scientists report the discovery of an increased level of the neuroprotein sortilin in pancreatic cancer cells that may open up the way to developing more effective treatment.
There is currently no good therapy for pancreatic cancer. What we …
-
Business17 hours agoBroker names 2 small cap ASX shares to buy for big returns
-
Noosa News23 hours agoQueenslanders not out of the woods as more storms, heatwave conditions to continue after horror three days
-
Noosa News17 hours agoDid AI write your accounting expert’s report? – Proctor
-
Noosa News18 hours agoYear 12 student from Wellington Point State High School dies four days before graduation